Glass House Brands (GLAS) Long-Term Deferred Tax (2020 - 2023)
Glass House Brands' (GLAS) quarterly Long-Term Deferred Tax came in at $1.6 million in Q2 2023, up 103.0% year-on-year from $772675.0 in Q2 2022, and up 9.24% on a QoQ basis from $1.4 million in Q1 2023.
Glass House Brands (GLAS) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Long-Term Deferred Tax data on file, last reported at $1.6 million in Q2 2023.
- On a quarterly basis, Long-Term Deferred Tax rose 103.0% year-over-year to $1.6 million in Q2 2023; TTM through Jun 2023 was $1.6 million, a 103.0% increase from a year earlier, with the FY2022 full-year figure at $1.5 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q2 2023 stood at $1.6 million, up from $1.4 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for GLAS reached as high as $1.6 million in Q2 2023 and fell as low as $354251.0 in Q1 2021.
- Historically, Long-Term Deferred Tax has averaged $960488.6 across 4 years, with a median of $754499.5 in 2022.
- Across the five-year window, Long-Term Deferred Tax surged 99.16% in 2022 and soared 103.51% in 2023, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $598435.0 in 2020, then tumbled by 40.8% to $354251.0 in 2021, then jumped by 326.91% to $1.5 million in 2022, then gained by 3.71% to $1.6 million in 2023.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $1.6 million in Q2 2023, $1.4 million in Q1 2023, and $1.5 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 736,324.00 |
| Jun 30, 2022 | 772,675.00 |
| Mar 31, 2022 | 705,542.00 |
| Mar 31, 2021 | 354,251.00 |
| Dec 31, 2020 | 598,435.00 |